Conatus Pharmaceuticals(CNAT)- NASDAQ
From other sites
Company Description
Conatus Pharmaceuticals, Inc. is a biotechnology company engages in the development and commercialization of medicines to liver diseases treatment. It focuses in development of Emricasan, orally active protease inhibitor designed to reduce the activity of enzymes that mediate inflammation and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States